The amplicon libraries were prepared following the standard protocol of the NEBNext ® Ultra™ II DNA Library Prep Kit for Illumina ® (New England Biolabs, United States). The constructed libraries were ...

These solutions leverage the power of Illumina's leading NovaSeq X series platform and will enable researchers to derive breakthrough insights around the drivers of disease. The company will also ...

As Illumina transitions to its new NovaSeq X platform and implements cost-cutting measures, investors and analysts are closely watching to see if the company can maintain its market leadership and ...

Illumina is raising the curtain on its upcoming ... The company said its spatial technology will run on its current NextSeq and NovaSeq hardware through a new multimodal software platform, with ...

Illumina will seek to cut $100 million in expenses ... multimodal software platform that runs on its current NextSeq and NovaSeq hardware. The company is also developing what it describes as ...

Illumina faces significant challenges from China's "unreliable entity list" and competition from Roche's new SBX technology, impacting its growth prospects. Despite a 37% stock decline since ...

Illumina has unveiled a new spatial technology that is designed to unlock further sequencing capabilities for researchers. Due for release in 2026, the US company’s technology for whole ...

While Illumina has faced pricing headwinds, particularly with the NovaSeq X transition, some analysts believe that a significant portion of these challenges have already been absorbed. This could ...

The spatial solution surpasses industry standards for scale and accuracy, and is compatible with Illumina NextSeq and NovaSeq sequencers, thereby materially reducing the cost of running large ...